Detalles de la búsqueda
1.
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy].
Rinsho Ketsueki
; 56(4): 392-9, 2015 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-25971269
2.
MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy.
Cancer Sci
; 104(12): 1670-4, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24112697
3.
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.
Ann Hematol
; 94(11): 1935-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26208667
4.
[ABVD chemotherapy for Hodgkin lymphoma at a single institute].
Rinsho Ketsueki
; 51(12): 1756-61, 2010 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-21258185
5.
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Rinsho Ketsueki
; 46(5): 350-7, 2005 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-16444968
6.
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy.
Leuk Res
; 39(2): 198-203, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25541027
7.
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
Gan To Kagaku Ryoho
; 29(2): 273-9, 2002 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-11865634
8.
Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma.
Int J Hematol
; 96(2): 241-6, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22684897
9.
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Leuk Lymphoma
; 49(11): 2133-40, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19021056
10.
Prognostic factors in diffuse large B-cell lymphoma treated by risk-adopted therapy.
Intern Med
; 45(5): 247-52, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16595988
Resultados
1 -
10
de 10
1
Próxima >
>>